Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04MFW
|
||||
| Former ID |
DIB011340
|
||||
| Drug Name |
DL-3
|
||||
| Synonyms |
DL-3
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Investigative | [1572605] | ||
| Company |
University of Cincinnati
|
||||
| Canonical SMILES |
C(C)(C)(c1ccc(OCCSc2[nH]c(cc(=O)n2)N)cc1)C
|
||||
| Target and Pathway | |||||
| Target(s) | Androgen receptor | Target Info | Antagonist | [1572605] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.